Related Experiment Videos
The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity
Christopher V Nicchitta1, Deanna M Carrick, Julie C Baker-Lepain
1Department of Cell Biology, Duke University Medical Center, Box 3709, Durham, NC 27710, USA. c.nicchitta@cellbio.duke.edu
Cell Stress & Chaperones
|January 7, 2005
Summary
Tumor-derived stress proteins like Hsp70 and gp96 (GRP94) can trigger antitumor immunity. This review examines how these proteins, through their peptide-binding function, activate immune cells to suppress tumor growth and metastasis.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Tumor-derived stress proteins, including Hsp70 and gp96 (GRP94), have demonstrated the ability to induce antitumor immune responses in preclinical models.
- These responses are characterized by suppressed tumor growth and reduced metastasis.
Purpose of the Study:
- To review the molecular mechanisms underlying the antitumor effects of stress proteins.
- To examine the hypothesis that the peptide-binding function of stress proteins is central to their immunomodulatory activity.
Main Methods:
- This review critically examines existing literature and recent insights into peptide generation and antigen presentation pathways.
- The focus is on how stress proteins interact with these cellular processes.
Main Results:
- Stress proteins bind antigenic peptides from their parent tumor cells.
- Tumor-derived stress protein-peptide complexes are processed by antigen-presenting cells (APCs).
- This processing leads to the activation of tumor-specific cytotoxic T lymphocytes.
Conclusions:
- Stress proteins play a crucial role in linking tumor antigen processing and presentation to the immune system.
- Their function in protein folding intersects with pathways for generating and assembling peptide antigens on MHC class I molecules.
- Understanding these interactions is key to developing novel cancer immunotherapies.